Wealthcare Capital Management LLC Gilead Sciences, Inc. Transaction History

Wealthcare Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $8,695 - $9,500	-137 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $8,220 - $9,379	137 New	137 $9,000
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $2,459 - $2,856	-34 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $4,258 - $5,454	-68 Reduced 66.67%	34 $3,000
Q4 2019 Jan 29, 2020	BUY	$61.62 - $67.78 $6,285 - $6,913	102 New	102 $7,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wealthcare Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Capital Management LLC with notifications on news.